immune system
N |
• mice exhibit normal class switch recombination
|
Allele Symbol Allele Name Allele ID |
Nabp2tm1.1Kkha targeted mutation 1.1, Kum Kum Khanna MGI:5502334 |
||||||||||||
Summary |
2 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• mice exhibit normal class switch recombination
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
Testicular degeneration in Nabp2tm1.1Kkha/Nabp2tm1.1Kkha Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ mice
• in tamoxifen-treated mice
|
N |
• tamoxifen-treated female mice exhibit normal fertility
|
• premature sloughing from the supporting Sertoli cells in tamoxifen-treated mice
|
• due to apoptosis and premature sloughing from the supporting Sertoli cells in tamoxifen-treated mice
• decreased elongated spermatids
|
• in tamoxifen-treated mice
|
• in tamoxifen-treated mice
|
• in tamoxifen-treated mice
|
• bilateral degeneration; tubules showed degenerate, sometimes vacuolated, or
necrotic spermatogenic cells, the latter with pyknotic nuclei and
hypereosinophilic cytoplasm, or apoptotic body formation in tamoxifen-treated mice
|
• from tamoxifen-treated mice with longer intervals between litters
|
• in tamoxifen-treated mice
|
• splenic and metastatic B lymphomas, T cell lymphoma in thymus, hepatocellular carcinoma and B or T lymphoblastic leukemia in 11 of 35 of tamoxifen-treated mice
|
• in thymus of some tamoxifen-treated mice
|
• in some tamoxifen-treated mice
|
• B or T lymphoblastic leukemia in some tamoxifen-treated mice
|
• splenic and metastatic B lymphomas in some tamoxifen-treated mice
|
• premature sloughing from the supporting Sertoli cells in tamoxifen-treated mice
|
• due to apoptosis and premature sloughing from the supporting Sertoli cells in tamoxifen-treated mice
• decreased elongated spermatids
|
• tamoxifen-treated mice exposed to ionizing radiation exhibit distended crypt lumina lined by attenuated enterocytes, desquamated necrotic cellular debris and a small increase of cells near deep crypts with apoptotic bodies
• however, blood counts are normal in irradiated tamoxifen-treated mice
|
• in irradiated tamoxifen-treated mice
|
• in tamoxifen-treated mice
|
• in tamoxifen-treated mice
|
• at E14.5 and E18.5
|
• tamoxifen-treated mice exposed to ionizing radiation exhibit distended crypt lumina lined by attenuated enterocytes, desquamated necrotic cellular debris and a small increase of cells near deep crypts with apoptotic bodies
|
• in irradiated tamoxifen-treated mice
|
• in thymus of some tamoxifen-treated mice
|
• in irradiated tamoxifen-treated mice
|
• in thymus of some tamoxifen-treated mice
|
• in tamoxifen-treated mice
|
• in tamoxifen-treated mice
|
• bilateral degeneration; tubules showed degenerate, sometimes vacuolated, or
necrotic spermatogenic cells, the latter with pyknotic nuclei and
hypereosinophilic cytoplasm, or apoptotic body formation in tamoxifen-treated mice
|
N |
• blood counts are normal in irradiated tamoxifen-treated mice
|
• in irradiated tamoxifen-treated mice
|
• in thymus of some tamoxifen-treated mice
|
• in tamoxifen-treated mice
|
• in some tamoxifen-treated mice
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|